Congenital hypogonadotropic hypogonadism and micropenis: effect of testosterone treatment on adult penile size why sex reversal is not indicated
- PMID: 10228293
- DOI: 10.1016/s0022-3476(99)70244-1
Congenital hypogonadotropic hypogonadism and micropenis: effect of testosterone treatment on adult penile size why sex reversal is not indicated
Abstract
Micropenis is commonly due to fetal testosterone deficiency. The clinical management of this form of micropenis has been contentious, with disagreement about the capacity of testosterone treatment to induce a functionally adequate adult penis. As a consequence, some clinicians recommend sex reversal of affected male infants. We studied 8 male subjects with micropenis secondary to congenital pituitary gonadotropin deficiency from infancy or childhood to maturity (ages 18 to 27 years). Four patients were treated with testosterone before 2 years of age (group I) and four between age 6 and 13 years (group II). At presentation, the mean penile length in group I was 1.1 cm (-4 SD; range, 0.5 to 1.5 cm) and in group II it was 2.7 cm (-3.4 SD; range, 1.5 to 3.5 cm). All patients received one or more courses of 3 intramuscular injections of testosterone enanthate (25 or 50 mg) at 4-week intervals in infancy or childhood. At the age of puberty the dose was gradually increased to 200 mg monthly and later to an adult replacement regimen. As adults, both group I and II had attained a mean final penile length of 10.3 cm 2.7 cm with a range of 8 to 14 cm (mean adult stretched penile length for Caucasians is 12.4 2.7 cm). Six of 8 men were sexually active, and all reported normal male gender identity and psychosocial behavior. We conclude that 1 or 2 short courses of testosterone therapy in infancy and childhood augment penile size into the normal range for age in boys with micropenis secondary to fetal testosterone deficiency; replacement therapy at the age of puberty results in an adult size penis within 2 SD of the mean. We found no clinical, psychologic, or physiologic indications to support conversion of affected male infants to girls. Further, the results of this study do not support the notion, derived from data in the rat, that testosterone treatment in infancy or childhood impairs penile growth in adolescence and compromises adult penile length.
Similar articles
-
Micropenis. II. Hypogonadotropic hypogonadism.Johns Hopkins Med J. 1980 May;146(5):177-84. Johns Hopkins Med J. 1980. PMID: 7382242
-
The androgen insensitive micropenis: long-term follow-up into adulthood.J Pediatr Endocrinol Metab. 2004 Aug;17(8):1037-41. doi: 10.1515/jpem.2004.17.8.1037. J Pediatr Endocrinol Metab. 2004. PMID: 15379413
-
Fate of the micropenis and constitutional small penis: do they grow to normalcy in puberty?J Pediatr Urol. 2019 Oct;15(5):526.e1-526.e6. doi: 10.1016/j.jpurol.2019.07.009. Epub 2019 Jul 23. J Pediatr Urol. 2019. PMID: 31447312
-
[Micropenis in children: etiology, diagnosis and therapy].Ned Tijdschr Geneeskd. 1997 Mar 15;141(11):511-5. Ned Tijdschr Geneeskd. 1997. PMID: 9190506 Review. Dutch.
-
Sexual quality of life after hormonal and surgical treatment, including phalloplasty, in men with micropenis: a review.J Sex Med. 2013 Dec;10(12):2890-903. doi: 10.1111/jsm.12298. Epub 2013 Aug 23. J Sex Med. 2013. PMID: 23981815 Review.
Cited by 35 articles
-
Congenital Micropenis: Etiology And Management.J Endocr Soc. 2021 Nov 15;6(2):bvab172. doi: 10.1210/jendso/bvab172. eCollection 2022 Feb 1. J Endocr Soc. 2021. PMID: 35036822 Free PMC article. Review.
-
Recent advancement in the treatment of boys and adolescents with hypogonadism.Ther Adv Endocrinol Metab. 2022 Jan 5;13:20420188211065660. doi: 10.1177/20420188211065660. eCollection 2022. Ther Adv Endocrinol Metab. 2022. PMID: 35035874 Free PMC article. Review.
-
Testosterone therapy in children and adolescents: to whom, how, when?Int J Impot Res. 2022 Jan 7. doi: 10.1038/s41443-021-00525-5. Online ahead of print. Int J Impot Res. 2022. PMID: 34997199 Review.
-
Advances in Genetic Diagnosis of Kallmann Syndrome and Genetic Interruption.Reprod Sci. 2021 Jul 6. doi: 10.1007/s43032-021-00638-8. Online ahead of print. Reprod Sci. 2021. PMID: 34231173 Review.
-
Nonsense-associated altered splicing of MAP3K1 in two siblings with 46,XY disorders of sex development.Sci Rep. 2020 Oct 15;10(1):17375. doi: 10.1038/s41598-020-74405-1. Sci Rep. 2020. PMID: 33060765 Free PMC article.
Publication types
MeSH terms
Substances
Grant support
LinkOut - more resources
Full Text Sources
Medical
Research Materials
